Brief: Harpoon Therapeutics Inc - QTRLY Loss Per Share $0.53

Harpoon Therapeutics

10/08/2022 21:55

Harpoon Therapeutics Inc  HARP.O :
    * HARPOON THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 REVENUE $8.3 MILLION
    * CURRENT CASH IS EXPECTED TO FUND OPERATIONS INTO SECOND
HALF OF
2023
    * QTRLY LOSS PER SHARE $0.53
    * Q2 EARNINGS PER SHARE VIEW $-0.56, REVENUE VIEW $7.0
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX79wflM 
Further company coverage:  HARP.O